NDC 0049-2040

Cardura XL

Doxazosin

Cardura XL is a Oral Tablet, Multilayer, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Roerig. The primary component is Doxazosin Mesylate.

Product ID0049-2040_00e2101f-d178-4941-8244-aa5282995893
NDC0049-2040
Product TypeHuman Prescription Drug
Proprietary NameCardura XL
Generic NameDoxazosin
Dosage FormTablet, Multilayer, Extended Release
Route of AdministrationORAL
Marketing Start Date2021-01-21
Marketing CategoryNDA /
Application NumberNDA021269
Labeler NameRoerig
Substance NameDOXAZOSIN MESYLATE
Active Ingredient Strength4 mg/1
Pharm ClassesAdrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0049-2040-10

30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (0049-2040-10)
Marketing Start Date2021-01-21
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Cardura XL" or generic name "Doxazosin"

NDCBrand NameGeneric Name
0049-2720Cardura XLCardura XL
0049-2710Cardura XLCardura XL
0049-2040Carduradoxazosin
0049-2080Carduradoxazosin
0049-2410Carduradoxazosin
0049-2512Carduradoxazosin
0049-2614Carduradoxazosin
0904-5522DoxazosinDoxazosin
0904-5523DoxazosinDoxazosin
0904-5524DoxazosinDoxazosin
16729-211DoxazosinDoxazosin
16729-213DoxazosinDoxazosin
16729-414DoxazosinDoxazosin
16729-415DoxazosinDoxazosin
23155-092DoxazosinDoxazosin
23155-093DoxazosinDoxazosin
23155-094DoxazosinDoxazosin
23155-095DoxazosinDoxazosin
42291-258DoxazosinDoxazosin

Trademark Results [Cardura]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CARDURA
CARDURA
73528813 1360101 Live/Registered
PFIZER INC.
1985-03-25
CARDURA
CARDURA
72144546 0747425 Live/Registered
Shell Oil Comany
1962-05-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.